Status:
WITHDRAWN
tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Halo Neuroscience
Conditions:
Nonfluent Aphasia, Progressive
Primary Progressive Nonfluent Aphasia
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
The investigators will test the feasibility of using transcranial direct current stimulation (tDCS) and speech therapy to treat participants with motor speech disorders caused by Frontotemporal Lobar ...
Eligibility Criteria
Inclusion
- Mini Mental Status Exam score \> 10
- diagnosis of nfvPPA via Gorno-Tempini 2011 criteria, or a diagnosis of FTLD syndrome including progressive supranuclear palsy, corticobasal syndrome or behavioral variant frontotemporal dementia PLUS a motor speech disorder (apraxia of speech and/or dysarthria)
- able to give consent
- right-handed
- native English speaker
- having a caregiver who is also able to sign and understand the caregiver's consent form.
Exclusion
- History of:
- stroke
- TBI
- brain cancer
- seizures
- craniotomy, skull surgery or fracture
- metallic implant in head
- pacemaker or cardioverter-defibrillator
- pregnancy.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04883229
Start Date
July 1 2022
End Date
November 30 2023
Last Update
August 19 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.